BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32425365)

  • 1. Why should we use convalescent plasma for COVID-19?
    Franchini M
    Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of convalescent plasma for COVID-19 treatment. History and evidence].
    McAllister F; Mantegazza A; Garzón F; Rotbaum V; Remondino G; Vazquez Larsson M; Geffner J; Rabinovich GA; Bover L
    Medicina (B Aires); 2020; 80 Suppl 3():82-86. PubMed ID: 32658853
    [No Abstract]   [Full Text] [Related]  

  • 4. Convalescent plasma for covid-19.
    Estcourt LJ; Roberts DJ
    BMJ; 2020 Sep; 370():m3516. PubMed ID: 32933945
    [No Abstract]   [Full Text] [Related]  

  • 5. Convalescent plasma to treat COVID-19.
    Bloch EM
    Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
    [No Abstract]   [Full Text] [Related]  

  • 6. Convalescent Plasma and COVID-19.
    Malani AN; Sherbeck JP; Malani PN
    JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
    [No Abstract]   [Full Text] [Related]  

  • 7. Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
    Rabelo-da-Ponte FD; Silvello D; Scherer JN; Ayala AR; Klamt F
    J Infect Dis; 2020 Oct; 222(9):1575-1578. PubMed ID: 32777038
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 10. Convalescent plasma is ineffective for covid-19.
    Pathak EB
    BMJ; 2020 Oct; 371():m4072. PubMed ID: 33093025
    [No Abstract]   [Full Text] [Related]  

  • 11. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
    Prajapati S
    Homeopathy; 2020 Aug; 109(3):184-185. PubMed ID: 32645727
    [No Abstract]   [Full Text] [Related]  

  • 12. The resurgence of convalescent plasma therapy.
    The Lancet Haematology
    Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
    Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
    Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convalescent fecal microbiota transplantation as a possible treatment for COVID-19.
    Apartsin K; Smirnova V
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):e113-e114. PubMed ID: 32917563
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of COVID-19 Virus Infection by Convalescent Plasma.
    Cheraghali AM; Abolghasemi H; Eshghi P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
    Garraud O
    Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
    [No Abstract]   [Full Text] [Related]  

  • 17. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors.
    Andersen KJ; Klassen SA; Larson KF; Ripoll JG; Senefeld JW; Clayburn AJ; Shepherd JRA; Tseng AS; Wiggins CC; Murphy BM; Ford SK; Johnson CP; Miller AD; Baker SE; Wright RS; Winters JL; Stubbs JR; Joyner MJ; van Buskirk CM
    Mayo Clin Proc; 2020 Nov; 95(11):2343-2349. PubMed ID: 33153626
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives.
    Tamburello A; Marando M
    Swiss Med Wkly; 2020 Apr; 150():w20264. PubMed ID: 32343358
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
    Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
    J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
    Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
    Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.